-
Observational study identifies drug that improves survival in sickest COVID-19 patients
worldpharmanews
August 20, 2020
Researchers at Hackensack Meridian Health, New Jersey's largest and most comprehensive health network, have utilized its statewide observational database of more than 5,000 hospitalized COVID-19 patients to show that a drug normally used in rheumatoid ...
-
Scientists identify hundreds of drug candidates to treat COVID-19
worldpharmanews
August 13, 2020
Scientists at the University of California, Riverside, have used machine learning to identify hundreds of new potential drugs that could help treat COVID-19, the disease caused by the novel coronavirus, or SARS-CoV-2.
-
US President orders government to buy drugs from domestic firms
pharmaceutical-technology
August 10, 2020
US President Donald Trump has signed an executive order that requires the federal government to purchase some essential medicines from domestic manufacturers.
-
NICE updates guidance on chronic pain treatments
pharmatimes
August 07, 2020
The UK’s National Institute for Health and Care Excellence (NICE) has published draft guidance which details how some commonly used drug treatments for chronic primary pain have little to no effect.
-
SomaLogic, Amgen Enter Proteomic Profiling Pact
contractpharma
July 31, 2020
Will use SomaLogic’s proteomics technology to help advance Amgen’s drug discovery and development programs.
-
FDA Proposes New Rule on Reporting Requirement Under Right to Try Act
americanpharmaceuticalreview
July 30, 2020
The U.S. Food and Drug Administration (FDA) published the proposed rule, Annual Summary Reporting Requirements Under the Right to Try Act, that when finalized, will implement a statutory requirement for sponsors and manufacturers to provide an annual ...
-
Clinical trials for COVID-19 treatments show mixed results, says study
europeanpharmaceuticalreview
April 17, 2020
Despite some positive results from clinical trials for COVID-19 treatments, separate tests of the same therapies have not met primary endpoints.
-
Applied Biology to Launch COVID-19 Drug Discovery Platform
contractpharma
April 08, 2020
Based on breakthrough discovery made in collaboration with Brown University researchers.
-
Drug supply chain disruptions due to COVID-19 a very high concern: Poll
pharmaceutical-technology
April 08, 2020
Analysis of a poll conducted by Verdict to assess the impact of COVID-19 on the drug supply chain showed that 90% are either highly or partially concerned about the disruption.
-
Evotec and Ildong Enter Drug Development Collaboration
contractpharma
April 02, 2020
Evotec SE has entered into a strategic collaboration with South Korean pharma firm, Ildong Pharmaceutical, to accelerate the development of several of Ildong's proprietary projects through access to Evotec's INDiGO platform.